breast lesion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 18–75 years old; 2. Diagnosed with breast nodules and scheduled for minimally invasive breast resection surgery; 3. American Society of Anesthesiologists (ASA) physical condition classification: I–III; 4. Surgery date between May 1, 2025 and November 30, 2025; 5. Complete preoperative assessment records, intraoperative anesthesia operation records, and 24-hour postoperative follow-up data; 6. Complete postoperative pain assessment records, including VAS at rest at 6 hours and 8 hours after surgery; 7. Complete record of celecoxib use within 24 hours after surgery.
Exclusion criteria
Exclusion criteria: 1. The presence of severe cardiac, pulmonary, liver, kidney dysfunction or other systemic diseases may affect the assessment of analgesic efficacy; 2. History of local anesthetic allergy or contraindications for regional nerve block; 3. Preoperative presence of chronic pain syndromes (such as neuropathic pain, fibromyalgia, etc.) or long-term use of analgesic drugs (> 3 months); 4. During the operation, conversion to general anesthesia, intraspinal anesthesia, or implementation of other regional blocks (such as intercostal nerve block); 5. Missing key information in the electronic medical record (such as postoperative VAS score, celecoxib usage record, block operation description, etc.), and unable to complete the filling in; 6. Preoperative had received other forms of regional nerve block; 7. Postoperative developed severe complications requiring hospitalization.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score at rest 8 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score at rest 6 hours after surgery;Usage of Celecoxib; | — |
Countries
China
Contacts
Shenshan Central Hospital, Sun Yat-sen Memorial Hospital, Sun Yat-sen University